|
[1]
|
祝兴林, 何剑斌, 赵玉军等. 犬细小病毒感染的研究现状[J]. 辽宁畜牧兽医, 2004, 10: 40-42.
|
|
[2]
|
李河林, 焦铁军, 刘淑红等. 犬细小病毒病研究进展[J]. 动物医学进展, 2008, 29(5): 73-77.
|
|
[3]
|
周云朵. 犬细小病毒的分离鉴定与生物学特性研究[D]. 华中农业大学, 2011.
|
|
[4]
|
王洪林. 犬细小病毒北京株分离和动物发病模型建立[D]. 中国农业科学院, 2009.
|
|
[5]
|
R. V. Pollock, L. E. Carmichael. Dog response to inactivated canine parvovirus and feline panleukopenia virus vaccines. Cor- nell Veterinarian, 1982, 72(1): 16-35.
|
|
[6]
|
S. H. Yoon, W. Jeong, H. J. Kim, et al. Molecular insights into the phylogeny of canine parvovirus 2 (CPV-2) with emphasis on Korean isolates: A Bayesian approach. Archives of Virology, 2009, 154(8): 1353-1360.
|
|
[7]
|
陈琛, 邬静, 张海亮等. 犬细小病毒病诊断与防治情况调查[J]. 湖北农业学, 2010, 59(8): 1926-1928.
|
|
[8]
|
A. Pratelli, A. Cavalli, G. Normanno, et al. Immunization of pups with maternally derived antibodies to canine parvovirus (CPV) using a modified-live variant (CPV-2b). Journal of Veterinary Medicine. B, Infectious Diseases and Veterinary Public Health, 2000, 47(4): 273-276.
|
|
[9]
|
夏咸柱, 叶俊华, 范泉水等. 犬细小病毒性肠炎弱毒疫苗的研究[J]. 兽医大学学报, 1989, 9(4): 325-329.
|
|
[10]
|
R. Arnon, T. Ben-Yedidia. Old and new vaccine approaches. International Immunopharmacology, 2003, 3(8): 1195-1204.
|
|
[11]
|
徐进, 孙世琪, 曹随忠等. 犬细小病毒基因工程疫苗的研究进展[J]. 中国兽医科学, 2012, 42(5): 541-544.
|
|
[12]
|
J. A. López de Turiso, E. Cortés, C. Martínez, et al. Recombi- nant vaccine for canine parvovirus in dogs. Journal of Virology, 1992, 66(5): 2748-2753.
|
|
[13]
|
J. P. Langeveld, J. I. Casal, A. D. Osterhaus, et al. First peptide vaccine providing protection against viral infection in the target animal: Studies of canine parvovirus in dogs. Journal of Virol- ogy, 1994, 68(7): 4506-4513.
|
|
[14]
|
王亚君, 华育平. 犬瘟热病毒抗原表位T’TB和犬细小病毒VP2蛋白的共表达及免疫小鼠特异性抗体的测定[J]. 兽类学报, 2009, 29(2): 204-209.
|
|
[15]
|
I. J. Amanna, M. K. Slifka. Wanted, dead or alive: New viral vaccines. Antiviral Research, 2009, 84(2): 119-130.
|
|
[16]
|
I. Castagliuolo, R. Piccinini, E. Beggiao, et al. Mucosal genetic immunization against four adhesins protects against Staphylo- coccus aureus-induced mastitis in mice. Vaccine, 2006, 24(20): 4393-4402.
|
|
[17]
|
C. Hatzifoti, Y. Roussel, A. G. Harris, et al. Mucosal immuniza- tion with a urease B DNA vaccine induces innate and cellular immune responses against helicobacter pylori. Helicobacter, 2006, 11(2): 113-122.
|
|
[18]
|
R. Liu, C. Zhou, D. Wang, et al. Enhancement of DNA vaccine potency by sandwiching antigen-coding gene between secondary lymphoid tissue chemokine (SLC) and IgG Fc fragment genes. Cancer Biology & Therapy, 2006, 5(4): 427-434.
|
|
[19]
|
W. Fuchs, J. Veits and T. C. Mettenleiter. Recombinant viruses of poultry as vector vaccines against fowl plague. Berliner und Munchener Tierarztliche Wochenschrift, 2006, 119(3-4): 160-166.
|
|
[20]
|
W. Jiang, H. J. Baker, L. J. Swango, et al. Nucleic acid immuni- zation protects dogs against challenge with virulent canine par- vovirus. Vaccine, 1998, 16(6): 601-607.
|
|
[21]
|
邱薇, 范泉水, 李作生等. 犬细小病毒核酸疫苗制备及免疫试验[J]. 动物医学进展, 2006, 27(3): 78-81.
|
|
[22]
|
陈同海, 孙志明, 赵福广等. CPV 基因疫苗对幼貂的免疫试验[J]. 经济动物学报, 2005, 9(2): 80-83.
|
|
[23]
|
Department of Health and Human Services. Points to consideron plasmid DNA vaccines for preventive infectious disease indica- tions. Office of the Federal Register, National Archives and Re- cords Administration, 1996, 61(250): 5-7.
|
|
[24]
|
WHO. Technical Report Series, 1998, 878: 107.
|